Conventional dendritic cells are required for the cross-presentation of leukemia-specific antigen in a model of AML relapse post-BMT.
Kate A MarkeyKate H GartlanRachel D KunsSteven W LaneGeoffrey R HillPublished in: Bone marrow transplantation (2018)